GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

PRU · Mar 31, 2024

PRUDENTIAL FINANCIAL INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001137774-24-000068Insurance
Cash82thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.cash

$18.7B · CORE · VALID

Policy-benefit growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.insurance.policy_benefits

61.04% · OPTIONAL · NOT_ENOUGH_HISTORY

Net-income growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.net_income

-22.16% · CORE · NOT_ENOUGH_HISTORY

Premium growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.insurance.premiums

65.94% · CORE · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

37.92% · CORE · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History17 statesSelf-history eligible
Period transition

What moved in the state?

Cash Decreased
Previous
$19.4B
Current
$18.7B
Delta
-$684.0M
Claims Growth Increased
Previous
-28.87%
Current
61.04%
Delta
89.92%
Premium Growth Increased
Previous
-28.03%
Current
65.94%
Delta
93.97%
Revenue Growth Increased
Previous
-10.11%
Current
37.92%
Delta
48.03%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.